Jakarta - Delayed Quote IDR

PT Metro Healthcare Indonesia Tbk (CARE.JK)

86.00 -24.00 (-21.82%)
At close: May 31 at 4:14 PM GMT+7
Loading Chart for CARE.JK
DELL
  • Previous Close 110.00
  • Open 110.00
  • Bid 81.00 x --
  • Ask 72.00 x --
  • Day's Range 86.00 - 113.00
  • 52 Week Range 86.00 - 545.00
  • Volume 65,397,800
  • Avg. Volume 2,838,807
  • Market Cap (intraday) 2.86T
  • Beta (5Y Monthly) -0.47
  • PE Ratio (TTM) --
  • EPS (TTM) -3.03
  • Earnings Date Jul 29, 2024 - Aug 2, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

PT Metro Healthcare Indonesia Tbk owns, operates, and manages hospitals in Indonesia. It is involved in the management of clinics, treatment halls, polyclinics, and other medical centers; healthcare, physical medicine, and trading businesses; operates private polyclinics; and provides industry, development, and services, as well as health and management consulting services. The company was founded in 2015 and is based in Tangerang, Indonesia. PT Metro Healthcare Indonesia Tbk is a subsidiary of PT Metro Healthcare International.

www.metrohealthcareindonesia.co.id

772

Full Time Employees

December 31

Fiscal Year Ends

Recent News: CARE.JK

Performance Overview: CARE.JK

Trailing total returns as of 5/31/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

CARE.JK
46.25%
IDX COMPOSITE
4.15%

1-Year Return

CARE.JK
82.08%
IDX COMPOSITE
5.04%

3-Year Return

CARE.JK
73.46%
IDX COMPOSITE
19.19%

5-Year Return

CARE.JK
33.85%
IDX COMPOSITE
42.04%

Compare To: CARE.JK

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: CARE.JK

Valuation Measures

Annual
As of 5/31/2024
  • Market Cap

    2.86T

  • Enterprise Value

    3.11T

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    10.53

  • Price/Book (mrq)

    0.93

  • Enterprise Value/Revenue

    11.44

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -37.16%

  • Return on Assets (ttm)

    -0.41%

  • Return on Equity (ttm)

    -3.22%

  • Revenue (ttm)

    271.52B

  • Net Income Avi to Common (ttm)

    -100.91B

  • Diluted EPS (ttm)

    -3.03

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    701.24B

  • Total Debt/Equity (mrq)

    30.79%

  • Levered Free Cash Flow (ttm)

    -66B

Research Analysis: CARE.JK

Company Insights: CARE.JK

Research Reports: CARE.JK

People Also Watch